000			02254 a2200613 4500
005			20250514170441.0
264		0	_c20040315
008			200403s 0 0 eng d
022			_a0022-3042
024	7		_a10.1046/j.1471-4159.2003.02214.x _2doi
040			_aNLM _beng _cNLM
100	1		_aBailey, Alexis
245	0	0	_aEnhanced morphine withdrawal and micro -opioid receptor G-protein coupling in A2A adenosine receptor knockout mice. _h[electronic resource]
260			_bJournal of neurochemistry _cFeb 2004
300			_a827-34 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aAutoradiography _xmethods
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBinding Sites
650	0	4	_aBrain _xanatomy & histology
650	0	4	_aDensitometry _xmethods
650	0	4	_aDiarrhea _xchemically induced
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- _xpharmacokinetics
650	0	4	_aGTP-Binding Proteins _xmetabolism
650	0	4	_aGuanosine 5'-O-(3-Thiotriphosphate) _xpharmacokinetics
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMorphine _xadverse effects
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNaloxone _xtherapeutic use
650	0	4	_aNarcotic Antagonists
650	0	4	_aRaclopride _xpharmacokinetics
650	0	4	_aReceptor, Adenosine A2A _xgenetics
650	0	4	_aReceptors, Opioid, mu _xmetabolism
650	0	4	_aSubstance Withdrawal Syndrome _xdrug therapy
650	0	4	_aSulfur Isotopes _xpharmacokinetics
650	0	4	_aTremor _xchemically induced
650	0	4	_aTritium _xpharmacokinetics
650	0	4	_aUrine _xphysiology
650	0	4	_aWeight Loss _xdrug effects
700	1		_aDavis, Lianne
700	1		_aLesscher, Heidi M B
700	1		_aKelly, Mary D W
700	1		_aLedent, Catherine
700	1		_aHourani, Susanna M O
700	1		_aKitchen, Ian
773	0		_tJournal of neurochemistry _gvol. 88 _gno. 4 _gp. 827-34
856	4	0	_uhttps://doi.org/10.1046/j.1471-4159.2003.02214.x _zAvailable from publisher's website
999			_c14480983 _d14480983